Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Dialectic: DETH Not Affected by Kelp DAO Attack

Dialectic: DETH Not Affected by Kelp DAO Attack

ForesightNewsForesightNews2026/04/21 12:38
Show original

Foresight News reports that crypto asset management firm Dialectic has released an update regarding its Dialectic Machines (DUSD, DETH, and DBIT) on the Makina platform in response to the recent KelpDAO attack. Dialectic stated that none of its products have direct exposure to rsETH risk. Although DETH maintains a position in the Aave Umbrella WETH vault, current analysis shows that the attack primarily involves rsETH OFT collateral on L2, rather than Ethereum mainnet positions. Since Aave Umbrella's automatic compensation mechanism only triggers slashing for losses on its deployed chain, losses on L2 cannot be covered by the WETH Umbrella on L1. Therefore, their assessment is that DETH will not be affected by this attack. As a precaution, Dialectic has initiated a redemption for this position, and it is now in a 20-day cooling-off period.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals

October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)

路透社•2026/10/09 04:26
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals

Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low

UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.

智通财经•2026/10/09 03:53